INTRODUCTION
Oxytocin is a nonapeptide produced in the hypo¬ thalamus as well as in several peripheral sites includ¬ ing the corpus luteum of ruminants (Wathes & Swann, 1982; Fields, Eldridge, Fuchs et al. 1983 ). Luteal oxytocin is located in the 'large' (granulosaderived) cells, where it is synthesized as a prohormone which is processed to produce oxytocin and neurophysin (Guldenaar, Wathes & Pickering, 1984; Swann, O'Shaughnessy, Birkett et al. 1984; . During the follicular phase, the oxytocin mRNA content of granulosa cells and the oxytocin content of the follicle are very low. However, oxytocin gene expression increases rapidly after ovulation, with the oxytocin mRNA content of the corpus luteum increasing over 100-fold within 2^1 days of ovulation (Ivell & Richter, 1984; Ivell, Brackett, Fields & Richter, 1985) . Oxytocin mRNA levels then decline, returning to preovulatory levels by the late luteal phase. Oxytocin peptide levels follow a similar pattern, with luteal oxytocin and the oxytocin concentration of luteal vein blood peaking in the midto late luteal phase Schams, 1987) .
Although release of luteal oxytocin late in the luteal phase appears to be acutely regulated by prostaglandins (Flint & Sheldrick, 1982 McCracken & Schramm, 1988) , little is known of the regulation of oxytocin production at earlier stages of the oestrous cycle. However, in serum-free cultures of bovine granulosa and luteal cells, insulin-like growth factor-I (IGF-I) is a potent stimulator of oxytocin and progesterone production (Schams, Koll & Li, 1988; Holtorf, Furuya, Ivell & McArdle, 1989; . Similar effects are produced with insulin (albeit at higher concentrations), but not by IGF-II Holtorf et al. 1989 ). These effects of IGF-I and insulin presumably reflect increased synthetic activity, because stimulation of oxytocin release is associated with raised oxytocin mRNA levels Furuya, McArdle & Ivell, 1990) , and stimulation of progesterone release from bovine granulosa cells is associated with increased cholesterol side-chain cleavage cytochrome P450 levels (Funkenstein, Waterman & Simpson, 1984) .
In cells of the early bovine corpus luteum, IGF-I-stimulated oxytocin production can be in¬ hibited by chronic PGF2a treatment (Luck & Junglas, 1987; (Ireland, Murphee & Coulson, 1980) . Cells from two to four corpora lutea were chopped into small pieces and dispersed in medium with collagenase (1 g/1), deoxyribonuclease (10mg/l) and amphotericin
(1-25 mg/1) as described (Pate & Condon, 1982; ). The cell suspension was then filtered through a nylon gauze and washed twice in culture medium. The cells were incubated in collagen-treated culture plates as described above for granulosa cells, at a plating density of approximately 3 105 cells/ml.
The cell number in the freshly prepared cell suspensions was estimated by measurement of DNA using a calf thymus DNA standard and assuming 1-4 105 cells to contain 1 µg DNA. The DNA assay was as previously described (Labarca & Paigen, 1980; assay buffer and frozen, thawed and sonicated before assay.
Hormone assays
Oxytocin was measured by RIA as described previously (Junglas & Luck, 1986) using 125I-labelled oxytocin and a sheep antibody against oxytocin (GJ 242/1) kindly provided by Professor A. P. F. Flint (Institute of Zoology, London). The working range of the assay was approximately 10-1000 pmol/l and inter-and intra-assay coefficients of variance were less than 7%. Progesterone was assayed using a commercial kit (RSL, Irvine, CA, U.S.A.) with a working range of approximately 0-6-160 pmol/l, and inter-and intra-assay coefficients of variance were less than 9%. The manufacturer's instructions were followed, except that all volumes were halved.
Statistical analysis
The results from pooled experiments were subjected to analysis of variance (ANOVA) of ranked data followed by Duncan (Fig. 1) . Insulin (17 nmol/1) also increased oxytocin and pro¬ gesterone release from these cells. In granulosa cells cultured with insulin, PGF2a (1 pmol/l) greatly increased oxytocin and progesterone release (Fig. 1), whereas the release of these hormones from luteal cells cultured with insulin was reduced by PGF2o (Fig. 1) (Fig. 2) . In contrast, insulin-stimulated oxytocin production from luteal cells was inhibited in a dose-dependent manner by PGF2o (Fig. 2) . Although the effects of PGF2a were more pronounced with insulin, high concentrations of PGF2a alone were able to stimulate and inhibit oxytocin release from granulosa and luteal cells respectively (Fig. 2) . Similar stimulation of progesterone production by PGF2a was also observed in granulosa cells (not shown). The PGF2a concentration producing a half-maximal response (EC50; 10-100 nmol/1, with insulin) was comparable in both cell preparations and for both (Fig. 2) (Fig. 2) (Fig. 4) . Since the highest dose of 
DISCUSSION
The ruminant corpus luteum is a major site of oxytocin synthesis (Wathes & Swann, 1982; Fields et al. 1983; Wathes et al. 1984) although the factors regulating oxytocin production in vivo are unknown. In vitro, oxytocin production by granulosa and luteal cell cultures can be increased by IGF-I or insulin (Schams et present study).
Since the intracellular oxytocin content at the start and end of granulosa and luteal cell cultures is extremely low in relation to oxytocin release during culture (Flint & Sheldrick, 1983) , implying action via release of oxytocin from a pre-existing secretory granule store (Heath, Weinstein, Merritt et al. 1983; Guldenaar et al. 1984; Rice, Jenkins & Thorburn, 1986) .
Several prostaglandins are produced by granulosa and luteal cells (Richards & Bagovich, 1982; Milvae & Hansel, 1983; Rodgers, Mitchell & Simpson, 1988) and levels of PGEs and PGF2a are particularly high in preovulatory follicles (Murdoch, Dailey & Inskeep, 1981) and the early corpus luteum (Milvae & Hansel, 1983) . These prostaglandins are thought to play a paracrine regulatory role, acting via specific cellsurface receptors. Receptors for both PGF2a and PGEs have been described in bovine corpora lutea (Powell, Hammerström & Samuelsson, 1975; Rao, 1975; Lin & Rao, 1978; Fitz, Mayan, Sawyer & Niswender, 1982) and the EC50 values reported here for PGF2a effects on hormone release in culture (10-100 nmol/1) are comparable with the reported dis¬ sociation constant for PGF2o binding to its receptor in the bovine corpus luteum (5-50 nmol/1; Rao, 1975; Powell et al. 1975 (Hintz, 1984) whereas both of these stimuli were more potent in the luteal cells. Alternatively, the luteal cells might release sufficient prostaglandin in culture to shift the insulin/ IGF-I dose-response curves to the left, as seen with exogenous PGF2a in granulosa cells (Fig. 3) . Again this seems unlikely, since the effects were observed in serum-free cultures, and prostaglandin production by other cell types is inhibited by removal of serum (Hassid, 1982) . Moreover, inclusion of indomethecin (2-50 µ / ) which inhibits prostaglandin synthesis by luteal cells (Milvae & Hansell, 1983; Rodgers, Mitchell & Simpson, 1988) , did not reduce the potency of insulin as a stimulator of hormone release from luteal cells (not shown). A third possibility is that the difference observed in culture reflects an increase in cellular responsiveness to IGF-I and insulin occurring during the periovulatory period in vivo. If so, the increase in insulin potency produced by PGF2a implies that the high levels of prostaglandin in the preovulatory follicle (Murdoch et al. 1981) 
